Garveys contributions to combination therapy research include: REDEFINE 1 trial leadership Guiding the pivotal Phase 3 trial demonstrating 20.4% mean weight loss with the combination Metabolic disease pathophysiology Extensive research on insulin resistance, adipose tissue biology, and energy metabolism Clinical trial design Decades of experience leading multi-center obesity and diabetes trials Translational research Bridging basic metabolic research with clinical application Guideline development Contributing to professional society guidelines for obesity and diabetes management His work has been instrumental in establishing combination therapy approaches as the next generation of obesity pharmacotherapy, demonstrating that targeting multiple complementary pathways can produce weight loss approaching bariatric surgery outcomes
doi: 10.3389/fimmu.2020.01720 99 MiyabeYMiyabeCMurookaTTKimEYNewtonGAKimNDet al
It also triggers angiogenesis by upregulating VEGF, flooding follicles with oxygen and nutrients for accelerated keratinocyte proliferation
The same central and peripheral mechanisms that suppress appetite can trigger nausea, vomiting, and early satiety as off-target effects
Minor side effects such as injection site pain, redness, or temporary headache are common and usually self-limiting
- Press the plunger down slowly to inject